Industrivarden AB operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industrivarden AB with three other
financial institutions in Europe:
sales of 235.02 million Euro [US$265.26 million]
of which 81%
was Financial Investments),
Deutsche Balaton AG
(186.45 million Euro [US$210.44 million]
of which 38%
was CornerstoneCapital), and
BB Biotech AG
based in Switzerland
(270.33 million Swiss Francs [US$268.45 million]
of which 100%
was Investing & Related Activity).
During the year ended December of 2017, sales at
Industrivarden AB were SEK 2.79 billion (US$307.71 million).
decrease of 9.5%
versus 2016, when the company's sales were SEK 3.08 billion.